Amylyx Pharmaceuticals shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Amylyx Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Amylyx Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Amylyx Pharmaceuticals by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $27M | 2.0M | 13.59 |
| 2025-03-31 | $7.1M | 2.0M | 3.54 |
| 2024-12-31 | $7.0M | 1.9M | 3.78 |
| 2024-09-30 | $5.2M | 1.6M | 3.24 |
| 2024-06-30 | $5.0M | 2.6M | 1.90 |
| 2024-03-31 | $8.4M | 2.9M | 2.84 |
| 2023-12-31 | $19M | 1.3M | 14.72 |
| 2023-09-30 | $22M | 1.2M | 18.31 |
| 2023-06-30 | $29M | 1.4M | 21.57 |
| 2023-03-31 | $40M | 1.4M | 29.34 |
| 2022-12-31 | $38M | 1.0M | 36.95 |